ATXS Astria Therapeutics, Inc.

7d ago, source: Seeking Alpha

Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for allergic and immunological diseases in the United States.

Astria Therapeutics, Inc. (NASDAQ:ATXS) is favoured by institutional owners who hold 53% of the company

27d ago, source: Yahoo Finance

Significantly high institutional ownership implies Astria Therapeutics' stock price ... you want to know who really controls Astria Therapeutics, Inc. (NASDAQ:ATXS), then you'll have to look ...

Astria Therapeutics Appoints Sunil Agarwal to Its Board of Directors

10d ago, source: Stockhouse

Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced the appointment of Sunil ...

Astria Therapeutics (NASDAQ: CATB)

22d ago, source: The Motley Fool

Astria Therapeutics, Inc. engages in the discovery, development, and commercialization of novel therapeutics. Its lead product candidate is STAR-0215, which is intended to treat Hereditary ...

Astria Therapeutics Reports Positive Initial Results From ALPHA-STAR Trial - Quick Facts

25d ago, source: Business Insider

(RTTNews) - Astria Therapeutics, Inc. (ATXS) reported positive initial proof-of-concept results from the ALPHA-STAR Phase 1b/2 clinical trial evaluating STAR-0215, a monoclonal antibody inhibitor ...

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

16d ago, source: Business Wire

BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, granted stock ...

Buy Rating Affirmed for Astria Therapeutics on Promising STAR-0215 Data and Market Potential

25d ago, source: Business Insider

Begin your TipRanks Premium journey today. Astria Therapeutics (ATXS) Company Description: Catabasis Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of novel ...

Astria Therapeutics, Inc. (ATXS)

4d ago, source: Yahoo Finance

BOSTON, April 09, 2024--Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced ...

Astria Therapeutics Inc ATXS

25d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Astria Therapeutics Inc.

23d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...